HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression

Apicidin, a cyclic peptide histone deacetylase (HDAC) inhibitor, has been demonstrated to exhibit antitumor activity in a number of human cancer types. The present study examined the antitumor activity of apicidin in murine oral squamous cell carcinoma (OSCC) cells. Inhibition of cell proliferation...

Descripción completa

Detalles Bibliográficos
Autor principal: Ahn, Mee-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202526/
https://www.ncbi.nlm.nih.gov/pubmed/30405794
http://dx.doi.org/10.3892/ol.2018.9468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202526/
https://www.ncbi.nlm.nih.gov/pubmed/30405794
http://dx.doi.org/10.3892/ol.2018.9468

Ejemplares similares